Short answer
Teleflex Inc (TFX) filed its Q3 2017 10-Q quarterly report on Aug 3, 2017 for the quarter ended Jul 2, 2017.
Teleflex Inc Q3 2017 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue $528.6M, up 11.6% YoY from $473.6M, including $49.8M from acquired businesses
- Gross margin 54.9% vs 54.1% YoY, SG&A margin 30.1% vs 30.2%
- Best segment All Other revenue $100.2M, up 73.0%; worst Asia operating profit $18.6M, down 14.5%
- Operating cash flow $197.7M vs $181.5M; acquisitions used $993.5M and capital expenditures totaled $36.8M
- Outlook: expected 2017 Asia sales and operating profit decline during China distributor-to-direct conversion; credit-market and customer-payment risks remained headwinds
Risk Factors
- No risk-factors section provided, preventing identification of new or changed risks versus the 2016 10-K
- Acquisition integration risk: Vascular Solutions generated a $11.6 million operating loss during the six months ended July 2, 2017
- Financial leverage risk: long-term borrowings increased to $1,887.7 million from $850.3 million after acquisition financing
- Restructuring execution risk: Vascular Solutions integration program estimated at $6.0 million to $7.5 million in charges through 2018
- Currency exposure: foreign-currency translation increased accumulated other comprehensive income by $112.7 million in six months
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Teleflex Inc quarterly reports
- Q3 2019 10-QFiled Oct 31, 2019
- Q2 2019 10-QFiled Aug 1, 2019
- Q1 2019 10-QFiled May 2, 2019
- Q3 2018 10-QFiled Nov 1, 2018
- Q3 2018 10-QFiled Aug 2, 2018
- Q2 2018 10-QFiled May 3, 2018
- Q4 2017 10-QFiled Nov 2, 2017
- Q2 2017 10-QFiled May 4, 2017
- Q3 2016 10-QFiled Oct 27, 2016
- Q2 2016 10-QFiled Jul 28, 2016
- Q1 2016 10-QFiled Apr 28, 2016
- Q3 2015 10-QFiled Oct 29, 2015
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.